|
CA3087742A1
|
|
Film-based dosage form
|
|
CA3044735A1
|
|
Water soluble cannabinoid formaltions comprising an enzyme
|
|
US2020375938A1
|
|
Water Soluble Formulation
|
|
CA2922959A1
|
|
Orally administrable composition
|
|
US2017252300A1
|
|
Orally administrable composition
|
|
CA2910206A1
|
|
Novel therapeutic composition
|
|
US2017112855A1
|
|
Therapeutic compositions comprising cannabidiol and corticosteroids
|
|
CA2872279A1
|
|
Topical lipolysis compositions and methods
|
|
US2015283080A1
|
|
Stabilized dermatological delivery system for active ingredient compositions for topical administration to the skin
|
|
US2015231069A1
|
|
Oral formulations of chemotherapeutic agents
|
|
US2015157728A1
|
|
Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
|
|
US2015104400A1
|
|
Topical delivery and administration system for stabilized protection agent, compositions and methods of making same
|
|
CA2738861A1
|
|
Photosensitizer composition for treating skin disorders
|
|
US2012283328A1
|
|
Photosensitizer composition for treating skin disorders
|
|
US2011027382A1
|
|
Solubilized benzoyl peroxyde acne
|
|
US2011033402A1
|
|
Solubilized benzoyl small molecule
|
|
US2012201857A1
|
|
Transdermal delivery system for therapeutics
|
|
US2011045096A1
|
|
Solubilized delivery system for topical anesthetics
|
|
US2009304820A1
|
|
Solubilized benzoyl peroxide topical drug formulation for the treatment of acne
|
|
US2008220021A1
|
|
Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
|
